NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sartorius Stedim Biotech S.A (PA: DIM)

 
DIM Technical Analysis
4
As on 5th Feb 2026 DIM STOCK Price closed @ 181.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 191.79 & Strong Sell for SHORT-TERM with Stoploss of 198.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DIMSTOCK Price

Open 180.75 Change Price %
High 183.90 1 Day 0.40 0.22
Low 179.05 1 Week -23.00 -11.25
Close 181.40 1 Month -25.40 -12.28
Volume 108027 1 Year 0.30 0.17
52 Week High 225.50 | 52 Week Low 152.90
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALNEV 0.00 %
ALNRG 0.01 %
ALALO 0.03 0.00%
ENGI 25.47 -2.04%
CGG 0.69 -2.82%
ACA 17.72 -2.53%
ORA 16.50 -0.30%
ALHYG 0.01 0.00%
 
PA France Top Gainers Stocks
PROAC 0.05 25.00%
ALDBT 0.06 20.00%
ALRPD 7.80 18.36%
ALMGI 2.34 14.71%
MLNMA 0.08 14.29%
ALSAF 0.99 12.50%
MLOCT 0.19 11.76%
ALINV 0.82 10.81%
ALCJ 2.18 10.66%
MLWEA 1.76 10.00%
 
PA France Top Losers Stocks
MLSML 0.03 -40.00%
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALUCI 3.10 -17.33%
ALEUP 0.05 -16.67%
MLCAC 13.60 -12.26%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
MLSDN 28.60 -11.18%
 
 
DIM
Daily Charts
DIM
Intraday Charts
Whats New @
Bazaartrend
DIM
Free Analysis
 
DIM Important Levels Intraday
RESISTANCE190.75
RESISTANCE187.75
RESISTANCE185.90
RESISTANCE184.04
SUPPORT178.76
SUPPORT176.90
SUPPORT175.05
SUPPORT172.05
 
DIM Forecast February 2026
4th UP Forecast247.98
3rd UP Forecast226.63
2nd UP Forecast213.43
1st UP Forecast200.23
1st DOWN Forecast162.57
2nd DOWN Forecast149.37
3rd DOWN Forecast136.17
4th DOWN Forecast114.82
 
DIM Weekly Forecast
4th UP Forecast223.89
3rd UP Forecast210.26
2nd UP Forecast201.84
1st UP Forecast193.42
1st DOWN Forecast169.38
2nd DOWN Forecast160.96
3rd DOWN Forecast152.54
4th DOWN Forecast138.91
 
DIM Forecast2026
4th UP Forecast356.85
3rd UP Forecast300.58
2nd UP Forecast265.8
1st UP Forecast231.02
1st DOWN Forecast131.78
2nd DOWN Forecast97
3rd DOWN Forecast62.22
4th DOWN Forecast5.95
 
 
DIM Other Details
Segment EQ
Market Capital 43451432960.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
DIM Address
DIM
 
DIM Latest News
 
Your Comments and Response on Sartorius Stedim Biotech S.A
 
DIM Business Profile
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Address: Zone Industrielle Les Paluds, Aubagne, France, 13781
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service